<DOC>
	<DOCNO>NCT00753025</DOCNO>
	<brief_summary>The purpose study determine whether autologous bone marrow derive cell isolated CD133+ fraction effective treatment limb ischemia</brief_summary>
	<brief_title>Autologous Bone Marrow For Lower Extremity Ischemia Treating</brief_title>
	<detailed_description>The number patient low limb obliterate atherosclerosis steadily grow compound 20-25 % kind cardiovascular pathology . At conservation tendency 2020 amputation percentage execute due vessel disease , reach 45 % . Hemodynamics improvement extremity surgery possible 40 - 70 % patient even widespread plural lesion artery , result always satisfactory . The actual problem angiosurgical help patient distal form arterial occlusion , due difficulty impossibility perform reconstructive intervention . In case operation indirect revascularization refer stimulation collateral blood flow carry . However , despite reach success , case result intervention give desirable effect , search new method treatment therefore necessary . To date perspective method neoangiogenesis stimulation cellular therapy gene-engineering technology . Experimental research model local limb ischemia show possibility use various cell neoangiogenesis stimulation . A number clinical research patient obliterate limb disease show efficacy cellular therapy even critical ischemia . However randomize , placebo-controlled research base principle evidence base medicine enough convincing conclusion .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Arteriosclerosis Obliterans</mesh_term>
	<criteria>obliterate low extremity atherosclerosis IIB stage ( Fontaine classification ) painless walk distance 1050 pulse absence аа . dorsalis pedis , tibialis posterior , poplitea absence ischemia rest necrotic change mainly distal form disease ( lesion superficial femoral artery , popliteal artery , anticnemion artery ) accord angiography testifies impossibility reconstructive operation performance patient lumbar sympathectomy tibial bone osteoperforations execute previously heavy smoker insulin depend diabetes myocardial infarction stroke within last year idiopathic hypertensia III stage anaemia diseases blood decompensation chronic disease contraindication surgical operation HIV infection virus hepatitis oncologic disease chemotherapy anamnesis</criteria>
	<gender>Male</gender>
	<minimum_age>39 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>low extremity ischemia</keyword>
	<keyword>Bone marrow</keyword>
	<keyword>Progenitor cell</keyword>
	<keyword>Neoangiogenesis</keyword>
</DOC>